What's New
Last Posted: Jun 01, 2020
- Targeted Immunosuppression Distinguishes COVID-19 from Influenza in Moderate and Severe Disease
Mudd PA, et al. medRxiv, May 30, 2020. - A ten-year China-US laboratory collaboration: improving response to influenza threats in China and the world, 2004-2014.
Shu Yuelong et al. BMC public health 2019 May (Suppl 3) 520 - Microbiome disturbance and resilience dynamics of the upper respiratory tract during influenza A virus infection.
Kaul Drishti et al. Nature communications 2020 May (1) 2537 - Circulating rather than alveolar extracellular DNA levels predict outcomes in influenza.
Zhang Nannan et al. The Journal of infectious diseases 2020 May - Adaptation of H9N2 Influenza Viruses to Mammalian Hosts: A Review of Molecular Markers.
Sun Xiangjie et al. Viruses 2020 May (5) - Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza.
Abbott Timothy R et al. Cell 2020 05 (4) 865-876.e12 - Swine-Origin H1 Influenza Viruses Isolated from Humans Exhibit Sustained Infectivity in an Aerosol State.
Pulit-Penaloza Joanna A et al. Applied and environmental microbiology 2019 05 (10) - Animal Disease Surveillance in the 21st Century: Applications and Robustness of Phylodynamic Methods in Recent U.S. Human-Like H3 Swine Influenza Outbreaks.
Alkhamis Moh A et al. Frontiers in veterinary science 2020 176 - Could Environment Affect the Mutation of H1N1 Influenza Virus?
Jiang Dong et al. International journal of environmental research and public health 2020 Apr (9) - mSphere of Influence: Predicting Immune Responses and Susceptibility to Influenza Virus-May the Data Be with You.
Ramos Irene et al. mSphere 2020 Mar (2)
No hay comentarios:
Publicar un comentario